Free Trial
NASDAQ:KLDO

Kaleido Biosciences (KLDO) Stock Price, News & Analysis

Kaleido Biosciences logo
$0.0020 +0.00 (+1,900.00%)
As of 09/26/2025 09:30 AM Eastern

About Kaleido Biosciences Stock (NASDAQ:KLDO)

Advanced

Key Stats

Today's Range
$0.0020
$0.0020
50-Day Range
$0.00
$0.35
52-Week Range
$0.00
$0.35
Volume
2,899 shs
Average Volume
10,546 shs
Market Capitalization
$85.25 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Kaleido Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
2nd Percentile Overall Score

KLDO MarketRank™: 

Kaleido Biosciences scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Kaleido Biosciences.

  • Earnings Growth

    Earnings for Kaleido Biosciences are expected to grow in the coming year, from ($2.27) to ($1.09) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Kaleido Biosciences is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Kaleido Biosciences is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    0.17% of the float of Kaleido Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Kaleido Biosciences has a short interest ratio ("days to cover") of 15.6, which indicates bearish sentiment.
  • Change versus previous month

  • Dividend Yield

    Kaleido Biosciences does not currently pay a dividend.

  • Dividend Growth

    Kaleido Biosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.17% of the float of Kaleido Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Kaleido Biosciences has a short interest ratio ("days to cover") of 15.6, which indicates bearish sentiment.
  • Change versus previous month

  • Search Interest

    7 people have searched for KLDO on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Kaleido Biosciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.00% of the stock of Kaleido Biosciences is held by insiders.

  • Percentage Held by Institutions

    81.56% of the stock of Kaleido Biosciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Kaleido Biosciences' insider trading history.
Receive KLDO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kaleido Biosciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KLDO Stock News Headlines

Kaleido Biosciences Inc (KLDO)
What The Silver Boom Could Mean For You…
AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-overlooked metal isn’t just about “green tech” anymore — it’s becoming critical to the AI revolution and modern energy systems. A new report explains why silver may be one of the most undervalued assets in the market today, and how everyday investors can use it to diversify and protect their savings. It also outlines a simple IRS-approved strategy that makes owning silver easier than most people realize.tc pixel
Kaleido Biosciences (OTC: KLDO)
See More Headlines

KLDO Stock Analysis - Frequently Asked Questions

Kaleido Biosciences' stock was trading at $0.0001 at the beginning of 2025. Since then, KLDO stock has increased by 1,900.0% and is now trading at $0.0020.

Kaleido Biosciences, Inc. (NASDAQ:KLDO) issued its earnings results on Monday, November, 1st. The company reported ($0.54) EPS for the quarter, meeting analysts' consensus estimates of ($0.54). The firm earned $0.10 million during the quarter, compared to analysts' expectations of $0.25 million.

Kaleido Biosciences (KLDO) raised $101 million in an IPO on Thursday, February 28th 2019. The company issued 4,800,000 shares at $20.00-$22.00 per share. Goldman Sachs, J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity was co-manager.

Shares of KLDO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Kaleido Biosciences investors own include Editas Medicine (EDIT), Enovix (ENVX), COMPASS Pathways (CMPS), Rambus (RMBS), Luminar Technologies (LAZR), Precision BioSciences (DTIL) and Globant (GLOB).

Company Calendar

Last Earnings
11/01/2021
Today
9/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Computer Software
Current Symbol
NASDAQ:KLDO
CIK
1751299
Fax
N/A
Employees
80
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$1.10 million
Price / Sales
0.08
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
42,623,000
Free Float
38,787,000
Market Cap
$85.25 thousand
Optionable
Not Optionable
Beta
-0.06

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:KLDO) was last updated on 9/29/2025 by MarketBeat.com Staff
From Our Partners